Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2005; 11(40): 6381-6384
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6381
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6381
Treatment | Inosine (%) | Cytidine (%) | Uridine (%) | Thymidine (%) | Adenosine(%) | Guanosine(%) |
0 mmol/L | 103.9±3.5a | 101.8±1.6a | 103.5±3.5a | 102.2±1.9a | 101.3±1.2a | 103.1±2.7a |
7.5 mmol/L | 94.0±1.2a | 92.0±3.8 a | 100.6±6.6a | 101.5±5.1a | ||
15 mmol/L | 69.5±1.8 a | 75.6±1.7 a | 99.1±2.8a | 99.0±0.3a | ||
30 mmol/L | 67.7±0.7a | 61.4±5.9a | 86.1±1.3a | 84.5±3.2a | ||
0.1 mmol/L | 93.0±5.2a | 86.3±3.5a | ||||
0.3 mmol/L | 80.9±2.0a | 89.4±2.1a | ||||
0.5 mmol/L | 78.4±1.8a | 86.3±3.3a |
- Citation: Yang SC, Chiu CL, Huang CC, Chen JR. Apoptosis induced by nucleosides in the human hepatoma HepG2. World J Gastroenterol 2005; 11(40): 6381-6384
- URL: https://www.wjgnet.com/1007-9327/full/v11/i40/6381.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i40.6381